NCT06569680
- Conditions
- Extranodal Marginal Zone Lymphoma
- Locations
-
- University of Miami Miami, Florida, United States
Clinical trial condition
Extranodal Marginal Zone Lymphoma
Explore clinical trials studying Extranodal Marginal Zone Lymphoma. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
Extranodal Marginal Zone Lymphoma trial results
Not Yet Recruiting
Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma
NCT07583810
- Conditions
- Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma, Extranodal Marginal Zone Lymphoma, Gastric Mucosa-Associated Lymphoid Tissue Lymphoma, +14 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT04465162
- Conditions
- Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Extranodal Marginal Zone Lymphoma
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Related conditions
- Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (1)
- Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (1)
- Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma (1)
- Gastric Mucosa-Associated Lymphoid Tissue Lymphoma (1)
- Hemic and Lymphatic Diseases (1)
- Immune System Diseases (1)
- Immunoproliferative Disorders (1)
- Lymphatic Diseases (1)